FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Jubilant Generics FDA-483

[ Price : $8.95]

FDA releases the form FDA-483 with six observations from an inspection at Indias Jubilant Generics.

NeuroOne Medical Brain Electrodes Get Clearance

[ Price : $8.95]

FDA clears a NeuroOne Medical Technologies 510(k) to market its Evo sEEG Electrode technology for temporary (less than 30 days) us...

Imjudo/Imfinzi Approved for Liver Cancer

[ Price : $8.95]

FDA approves AstraZenecas Imjudo (tremelimumab) in combination with Imfinzi (durvalumab) for treating adult patients with unresect...

Guidances on ANDA Bioequivalence for Topicals

[ Price : $8.95]

Federal Register notice: FDA makes available additional draft and revised draft product-specific guidances for developing topical ...

FDA Nixes Cefazolin as Surrogate Agent for Cephalosporins

[ Price : $8.95]

FDA determines there are insufficient data to support a proposed cefazolin susceptible minimum inhibitory concentration breakpoint...

Warning Letter Close Out for Innova Medical

[ Price : $8.95]

FDA closes out a Warning Letter issued to Innova Medical Group over its unauthorized Covid-19 test following a recent inspection t...

Gene Therapy Neurodegenerative Disease Guide

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Human Gene Therapy for Neurodegenerative Diseases; Guidance...

Gormley Adds Oncology Endpoint Role at FDA

[ Price : $8.95]

CDER Division of Hematologic Malignancies 2 division director Nicole Gormley is named acting associate director for oncology endpo...

AI Ultrasound Gains De Novo Backing for Nerve Block

[ Price : $8.95]

FDA grants Intelligent Ultrasound a de novo marketing authorization for its artificial intelligence ScanNav Anatomy Peripheral Ner...

Info Collection on Right to Try

[ Price : $8.95]

Federal Register notice: FDA sends to OMB a proposed information collection entitled Annual Summary Reporting Requirements Under t...